It would seem the Volition test may have a higher sensitivity detecting stage 1 cancer (80% vs 58% for ColoStat) but, with a lower specificity (78% vs 95% for ColoStat). My basic understanding is that this means Volition can identify cancer more accurately than Colostat (80% vs 58%), however, ColoStat is better at correctly identifying patients who DON'T have the cancer 95% of the time vs 78%).
The interim results demonstrated that a small panel of three ELISA assays, when considered with the subjects' ages and smoking histories, produced an area under the curve (AUC) of 83% and was able to detect 80% of Stage I CRC cases and 66% of High-Risk Adenomas (HRA) at 78% specificity, respectively.
https://volitionrx.com/news/press-r...0-subject-clinical-trial-in-colorectal-cancer
- Forums
- ASX - By Stock
- RHY
- Competition?
Competition?, page-4
Featured News
Add RHY (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.0¢ |
Change
-0.003(4.11%) |
Mkt cap ! $17.40M |
Open | High | Low | Value | Volume |
7.3¢ | 7.3¢ | 7.0¢ | $2.527K | 34.64K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5882 | 7.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.6¢ | 12800 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5882 | 0.070 |
1 | 35000 | 0.064 |
1 | 100000 | 0.062 |
1 | 5000 | 0.061 |
1 | 10000 | 0.060 |
Price($) | Vol. | No. |
---|---|---|
0.076 | 12800 | 1 |
0.077 | 12974 | 1 |
0.080 | 1140 | 1 |
0.084 | 43251 | 2 |
0.085 | 17407 | 1 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |